Cargando…
Ginsenoside Rg1 Inhibits STAT3 Expression by miR-15b-5p to Attenuate Lung Injury in Mice with Type 2 Diabetes Mellitus-Associated Pulmonary Tuberculosis
Type 2 diabetes mellitus (T2DM) has been regarded as a critical risk factor for pulmonary tuberculosis (PTB). Ginsenoside Rg1 has been identified as a potential therapeutic agent for T2DM by suppressing the inflammatory response. However, the effect of Rg1 on T2DM-associated PTB has not been reporte...
Autores principales: | Ma, Tingxi, Mao, Xiaohui, Meng, Xiangguo, Wang, Qinghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553455/ https://www.ncbi.nlm.nih.gov/pubmed/36248428 http://dx.doi.org/10.1155/2022/9017021 |
Ejemplares similares
-
Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition
por: Yun, Eunsik, et al.
Publicado: (2023) -
Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats
por: Liu, Guang, et al.
Publicado: (2022) -
Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
por: Xiao, Ming-He, et al.
Publicado: (2018) -
Protective effects of ginsenosides Rg1 and Rb1 against cognitive impairment induced by simulated microgravity in rats
por: Jiang, Ning, et al.
Publicado: (2023) -
Ginsenoside Rg3 protects mouse leydig cells against triptolide by downregulation of miR-26a
por: Liang, Haiyan, et al.
Publicado: (2019)